Summary
Latest filing:
Michaela Levin is Chief Business Officer of Acrivon Therapeutics, Inc. (ACRV). 1 SEC Form 4 filing on record, dated 2 September 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Michaela Levin has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michaela Levin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Peter Blume-Jensen - $117K of ACRV open-market activity in the last 12 months
- Eric Devroe - $18K of ACRV open-market activity in the last 12 months
- Adam D. Levy - $17K of ACRV open-market activity in the last 12 months
- Mary Miller - $1K of ACRV open-market activity in the last 12 months
- Erick Gamelin - $804 of ACRV open-market activity in the last 12 months
- Katharine Peterson - $203 of ACRV open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michaela Levin?
Michaela Levin is a corporate insider, tracked as Chief Business Officer of Acrivon Therapeutics, Inc. (ACRV). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michaela Levin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Michaela Levin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michaela Levin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
